Skip to main content

Animations

MJFF Publications

1381 - 1390 of 6403 Results
Title
Year
  • Year
  • 2024
  • 2013
  • 2016
  • 2025
  • 2013
  • 2024
  • 2021
  • 2020
  • 2020
  • 2024
  • Summary Details
    OPEN
    Title: Phosphoglycerate kinase is a central leverage point in Parkinson’s disease–driven neuronal metabolic deficits
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/sciadv.adn6016
    Citation Count: 8
  • Summary Details
    OPEN
    Title: A Neo-Substrate that Amplifies Catalytic Activity of Parkinson’s-Disease-Related Kinase PINK1
    Journal Name: Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.cell.2013.07.030
    Citation Count: 252
  • Summary Details
    OPEN
    Title: Loss of SYNJ1 dual phosphatase activity leads to early onset refractory seizures and progressive neurological decline
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/aww180
    Citation Count: 77
  • Summary Details
    OPEN
    Title: Type II kinase inhibitors that target Parkinson’s disease–associated LRRK2
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adt2050
    Citation Count: 0
  • Summary Details
    OPEN
    Title: The Sac1 Domain of SYNJ 1 Identified Mutated in a Family with Early‐Onset Progressive P arkinsonism with Generalized Seizures
    Journal Name: Human Mutation
    Publisher: Hindawi Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: unspecified-oa, unspecified-oa
    DOI - Digital Object Identifier: 10.1002/humu.22372
    Citation Count: 315
  • Summary Details
    OPEN
    Title: A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2
    Journal Name: Journal of Biological Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.jbc.2024.107469
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Remote smartphone monitoring of Parkinson’s disease and individual response to therapy
    Journal Name: Nature Biotechnology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41587-021-00974-9
    Citation Count: 117
  • Summary Details
    OPEN
    Title: Genetic variants and functional pathways associated with resilience to Alzheimer’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awaa209
    Citation Count: 126
  • Summary Details
    OPEN
    Title: The unfolded protein response is activated in the olfactory system in Alzheimer’s disease
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-020-00986-7
    Citation Count: 37
  • Summary Details
    OPEN
    Title: Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021
    Journal Name: The Lancet
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/s0140-6736(24)00685-8
    Citation Count: 296
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.